全文获取类型
收费全文 | 2267篇 |
免费 | 122篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 72篇 |
妇产科学 | 42篇 |
基础医学 | 315篇 |
口腔科学 | 32篇 |
临床医学 | 175篇 |
内科学 | 500篇 |
皮肤病学 | 121篇 |
神经病学 | 180篇 |
特种医学 | 196篇 |
外科学 | 261篇 |
综合类 | 19篇 |
一般理论 | 1篇 |
预防医学 | 140篇 |
眼科学 | 51篇 |
药学 | 143篇 |
中国医学 | 1篇 |
肿瘤学 | 117篇 |
出版年
2021年 | 21篇 |
2019年 | 21篇 |
2018年 | 36篇 |
2017年 | 24篇 |
2016年 | 20篇 |
2015年 | 31篇 |
2014年 | 34篇 |
2013年 | 69篇 |
2012年 | 75篇 |
2011年 | 84篇 |
2010年 | 57篇 |
2009年 | 49篇 |
2008年 | 70篇 |
2007年 | 109篇 |
2006年 | 93篇 |
2005年 | 104篇 |
2004年 | 90篇 |
2003年 | 82篇 |
2002年 | 86篇 |
2001年 | 71篇 |
2000年 | 100篇 |
1999年 | 67篇 |
1998年 | 35篇 |
1997年 | 36篇 |
1996年 | 28篇 |
1995年 | 23篇 |
1994年 | 20篇 |
1993年 | 29篇 |
1992年 | 41篇 |
1991年 | 38篇 |
1990年 | 54篇 |
1989年 | 46篇 |
1988年 | 45篇 |
1987年 | 38篇 |
1986年 | 45篇 |
1985年 | 45篇 |
1984年 | 32篇 |
1983年 | 27篇 |
1980年 | 24篇 |
1979年 | 29篇 |
1978年 | 23篇 |
1977年 | 26篇 |
1976年 | 23篇 |
1975年 | 22篇 |
1974年 | 36篇 |
1973年 | 22篇 |
1971年 | 18篇 |
1970年 | 23篇 |
1969年 | 19篇 |
1966年 | 16篇 |
排序方式: 共有2408条查询结果,搜索用时 0 毫秒
101.
102.
103.
104.
105.
Aortic valve replacement in patients who underwent previous coronary artery bypass with a patent internal thoracic artery is often a challenge because of the risk of graft injury during dissection or difficulties to obtain optimum myocardial protection. Different approaches to myocardial protection or internal thoracic graft dissection and control have been described. Endovascular control of the internal thoracic graft by an angioplasty balloon catheter positioned in the operating room before the operation can be a safe and simple alternative. We report the case of a patient who underwent this technique for aortic valve replacement. 相似文献
106.
Metz S 《Anesthesiology》2005,103(4):903-4; author reply 904
107.
108.
109.
Beck CA Metz LM Svenson LW Patten SB 《Multiple sclerosis (Houndmills, Basingstoke, England)》2005,11(5):516-519
OBJECTIVE: To describe the regional distribution of multiple sclerosis (MS) prevalence in Canada, controlling for age and sex. METHODS: This study used data from the Canadian Community Health Survey, a large general health survey (n = 131,535) conducted in 2000/2001. Subjects aged 18 and over were included in the current analysis (n = 116,109). The presence of MS was determined by self-report. Prevalence was computed in five regions (Atlantic, Quebec, Ontario, Prairies and British Columbia). Logistic regression was used to compare regions and examine for confounding/interaction by age and sex. RESULTS: The overall Canadian MS prevalence was 240 per 100000 (95%CI: 210 280). Prevalence ranged from 180 (95%CI: 90-260) in Quebec to 350 (95%CI: 230-470) in Atlantic Canada. Logistic regression revealed no statistical difference between the odds of MS in Quebec, Ontario and British Columbia adjusted for age and sex. The adjusted odds of MS in the Prairies and Atlantic regions were significantly higher than in the other regions combined, with odds ratios of 1.7 (95%CI: 1.1-2.4, P <0.01) and 1.6 (95%CI: 1.1-2.4, P <0.05) respectively. Sensitivity analysis demonstrated similar prevalence in the nonaboriginal/nonimmigrant group (n = 96219). CONCLUSION: Results suggest that Canadian MS prevalence differs by region. If validated, these regional differences may facilitate investigation of environmental influences. 相似文献
110.
Stéphane Chapuis Lemlih Ouchchane Olivier Metz Laurent Gerbaud Franck Durif 《Movement disorders》2005,20(2):224-230
The impact of motor complications of Parkinson's disease (PD), especially levodopa-induced dyskinesias, on quality of life (QL) was studied in 143 patients with PD. All were evaluated on the Hoehn and Yahr (H&Y) scale, and the Motor part of the Unified Parkinson's Disease Rating Scale (UPDRS). Motor complications were analyzed using the UPDRS Parts IV(A) and IV(B) and the Abnormal Involuntary Movement Scale. A specific Parkinson's disease quality of life questionnaire (39-item version, PDQ-39) was used. Motor complications significantly worsened the PDQ-39 Summary Index (PDQ-SI) of patients with PD. The dimensions of Mobility, Activities of Daily Living, Stigma, and Communication were the most strongly affected. "Peak dose" dyskinesia decreased Mobility, Emotional Well-Being, and Cognition, whereas biphasic dyskinesia affected Mobility, Stigma, Communication, and Activities of Daily Living. Morning akinesia, end-of-dose fluctuations, and "unpredictable offs" decreased QL on the dimensions of Mobility, Activities of Daily Living, Stigma, and Communication. Nocturnal akinesia led to a deterioration of all dimensions of the PDQ-39. Thus, motor complications and especially nocturnal akinesia and biphasic dyskinesias worsened the QL of PD patients. 相似文献